Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy

Journal of Investigative Dermatology

Volumn 126, Issue 12, 2006, Pages 2679-2686

  De Haas, Ellen R M ^a   Kruijt, Bastiaan ^a   Sterenborg, Henricus J C M ^a   Martino Neumann, H A ^a   Robinson, Dominic J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; ILLUMINATION; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; DARKNESS; HUMANS; LIGHT; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751119264     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700460     Document Type: Article

References (41)

1. af Klinteberg C, Enejder AMK, Wang I, Andersson-Engels S, Svanberg S, Svanberg K (1999) Kinetic fluorescence studies of 5-aminolevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J Photochem Photobiol B: Biol 49:120-8
2. Barr H, Tralau CJ, MacRobert AJ, Krasner N, Boulos PB, Clark CG et al. (1987) Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer 56:111-8
3. Bogaards A, Varma A, Zhang K, Zach D, Bisland SK, Moriyama EH et al. (2005) Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochem Photobiol Sci 4:438-42
4. Calzavara-Pinton PG (1995) Repetetive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 29:53-7
5. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson S (2003) Topical 5-aminolevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19:134-41
6. De Bruijn HS, van der Veen N, Robinson DJ, Star WM (1999) Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. Cancer Res 59:901-4
7. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P (1998) Long term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy. Arch Dermatol 134:821-6
8. Golub AL, Gudgin Dickson EF, Kennedy JC, Marcus SL, Park Y, Pottier RH (1999) The monitoring of ALA-induced protoporphyrin IX accumulation and clearance in patients with skin lesions by in vivo surface-detected fluorescence spectroscopy. Lasers Med Sci 14:112-22
9. Gudgin Dickson EF, Pottier RH (1995) On the role of protoporphyrin IX photoproducts in photodynamic therapy. J Photochem Photobiol B 29:91-3
10. Haller JC, Cairnduff F, Slack G, Schofiled J, Whitehurst C, Turnstall R et al. (2000) Routine double treatments of superficial basal cell carcinomas using aminolevulinic acid-based photodynamic therapy. Br J Dermatol 143:1270-4
11. Horn M, Wolf P, Wulf HC (2003) Topical aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149:1242-9
12. Ibbotson SH (2002) Topical 5-aminolevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 146:178-88
13. Kennedy JC, Pottier R, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143-8
14. Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275-92
15. Marchesini R, Pignoli E, Tomatis S, Fumagalli S, Sichirollo AE, Di Palma S et al. (1994) Ex vivo optical properties of human colon tissue. Lasers Surg Med 15:351-7
16. Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ et al. (1995) Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 287:665-74
17. Meijnders PJN, Star WM, De Bruijn HS, Treurniet-donker AD, van Mierlo MJM, Wijtthoff SJM et al. (1996) Clinical results of photodynamic therapy for superficial skin malignancies and actinic keratosis using topical 5-aminolevulinic acid. Lasers Med Sci 11:123-31
18. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH (1998) Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 134:248-9
19. Morton CA, Whitehurst C, Moseley H, McColl JH, oore JV, Mackie RM (1996) Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135:766-71
20. Orenstein A, Kostenich G, Malik Z (1997) The kinetics of fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett 120:229-34
21. Oseroff AR (1998) PDT for cutaneous malignancies: clinical applications and basic mechanisms. Photochem Photobiol 67:17S-8S
22. Pech O, Gossner L, May A, Rabenstein T, Vieth M, Stolte M et al. (2005) Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62:24-30
23. Presser SE, Taylor JR (1987) Clinical diagnostic accuracy of basal cell carcinoma. J Am Acad Dermatol 16:988-90
24. Rhodes LE, De Rie Enstrom Y, Groves R, Morken T, Goulden V et al. (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Arch Dermatol 140:17-23
25. Robinson DJ, de Bruijn HS, de Wolf WJ, Sterenborg HJ, Star WM (2000) Topical 5-aminolevulinic acid photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem Photobiol 72:794-802
26. Robinson DJ, de Bruijn HS, Star WM, Sterenborg HJ (2003) Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem Photobiol 77:319-23
27. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 67:140-9
28. Soler AM, Warloe T, Berner A, Giercksky HK (2001) A follow up study of recurrence and cosmesis in completely responding superficial and nodular basal call carcinomas treated with methyl-aminolevulinate based phorodynamic therapy alone and with prior curettage. Br J Dermatol 145:467-71
29. Soler AM, Warloe T, Tausjø J, Berner A (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one year follow-up study. Acta Dermatol Venerol 79:204-6
30. Star WM (1995) Diffusion theory of light transport. In: Optical-thermal response of laser-irradiated tissue (Welch AJ, van Gemert MJC, eds), New York: Plenum Press, pp 131-206
31. Star WM, van 't Veen AJ, Robinson DJ, Munte K, de Haas ERM, Sterenborg HJCM (2006) Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two equal light fractions with a two hour interval long term follow-up. Acta Dermatol Venerol (in press)
32. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S et al. (1994) Photodynamic therapy of nonmelanoma tumours of the skin using topical δ-aminolevulinic acid sensitisation and laser irradiation. Br J Dermatol 130:743-51
33. Thissen MR, de Blois MW, Robinson DJ, de Bruijn HS, Dutrieux RP, Star WM et al. (2002) PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination. J Invest Dermatol 118:239-45
34. Van den Akker JHTM, de Bruijn HS, Beijersbergen Henegouwen GJM, Star WM, Sterenborg HJCM (2000a) Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB induced early skin cancer. Photochem Photobiol 72:399-406
35. Van den Akker JTHM, Holroyd JA, Vernon DI, Sterenborg HJCM, Brown SB (2003) Comparative in vitro percutaneous penetration of 5-aminolevulinic acid and two of its esters through excised hairless mouse skin. Las Surg Med 3:173-81
36. Van den Akker JTHM, Iani V, Star WM, Sterenborg HJCM, Moan J (2000b) Topical application of 5-aminolevulinic acid hexyl aster and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72:681-9
37. Van den Akker JT, Boot K, Vernon DI, Brown SB, Groenendijk L, van Rhoon GC et al. (2004) Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 3:263-7
38. Van der Veen N, Hebeda KM, de Bruijn HS, Star WM (1999) Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single or two-fold illumination. Photochem Photobiol 70:921-9
39. Van der Veen N, van Leengoed HLLM, Star WM (1994) In vivo fluorescence kinetics and photodynamic therapy using 5-aminolevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 70:867-72
40. Van Iersel CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, Kiemeney LA et al (2005) Prognostic factors for a subsequent basal cell carcinoma: implications for follow up. Br J Dermatol 153:1078-9
41. Wennberg A-M, Lindholm LE, Alpsten M, Larkö O (1996) Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res 288:561-4